Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Eli Lilly & Co (LLY) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Eli Lilly & Co. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 59478.
Total stock buying since 2015: $8,218,370.
Total stock sales since 2015: $23,196,371,694.
Total stock option exercises since 2015: $14,061,172.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 6,987 | $4,537,241 | 1,163,250 | $4,554,322,244 | 17,390 | $0 |
| 2024 | 0 | $0 | 2,879,232 | $2,352,513,879 | 16,479 | $0 |
| 2023 | 0 | $0 | 3,210,312 | $11,902,712,132 | 128,773 | $0 |
| 2022 | 858 | $249,397 | 4,522,320 | $1,397,922,981 | 66,315 | $0 |
| 2021 | 1,366 | $249,793 | 3,428,533 | $800,353,310 | 168,003 | $0 |
| 2020 | 0 | $0 | 3,592,018 | $542,331,593 | 120,374 | $0 |
| 2019 | 14,016 | $1,522,398 | 3,603,616 | $436,202,568 | 78,579 | $0 |
| 2018 | 12,168 | $1,068,636 | 5,179,358 | $521,807,695 | 261,952 | $0 |
| 2017 | 0 | $0 | 2,407,515 | $200,673,199 | 183,310 | $0 |
| 2016 | 7,605 | $590,905 | 2,352,371 | $183,183,419 | 201,412 | $0 |
| 2015 | 0 | $0 | 3,775,670 | $304,348,674 | 433,658 | $14,061,172 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-07-26 | Lilly Endowment Inc (10% Owner) | Sale | 1,601 | 332.52 | 532,370 |
| 2022-07-15 | Lilly Endowment Inc (10% Owner) | Sale | 17,310 | 334.00 | 5,781,470 |
| 2022-07-06 | Lilly Endowment Inc (10% Owner) | Sale | 177,243 | 330.88 | 58,645,809 |
| 2022-06-28 | Lilly Endowment Inc (10% Owner) | Sale | 900 | 329.01 | 296,109 |
| 2022-06-27 | Lilly Endowment Inc (10% Owner) | Sale | 41,857 | 329.05 | 13,772,836 |
| 2022-06-24 | Lilly Endowment Inc (10% Owner) | Sale | 215,000 | 323.95 | 69,648,605 |
| 2022-06-23 | Lilly Endowment Inc (10% Owner) | Sale | 205,000 | 311.37 | 63,830,440 |
| 2022-06-22 | Lilly Endowment Inc (10% Owner) | Sale | 210,000 | 307.35 | 64,543,290 |
| 2022-06-01 | Rau Diogo (SVP & CIDO) | Option Ex | 7,560 | .00 | 0 |
| 2022-06-01 | Zakrowski Donald A (Chief Accounting Officer) | Sale | 1,000 | 313.44 | 313,440 |
| 2022-05-27 | Lilly Endowment Inc (10% Owner) | Sale | 200,000 | 318.86 | 63,771,400 |
| 2022-05-26 | Lilly Endowment Inc (10% Owner) | Sale | 178,390 | 311.04 | 55,486,425 |
| 2022-05-25 | Lilly Endowment Inc (10% Owner) | Sale | 41,610 | 309.36 | 12,872,469 |
| 2022-05-24 | Lilly Endowment Inc (10% Owner) | Sale | 100,000 | 306.01 | 30,600,700 |
| 2022-05-23 | Lilly Endowment Inc (10% Owner) | Sale | 118,856 | 303.37 | 36,056,869 |
| 2022-05-18 | Lilly Endowment Inc (10% Owner) | Sale | 700 | 302.00 | 211,400 |
| 2022-05-17 | Lilly Endowment Inc (10% Owner) | Sale | 19,683 | 302.73 | 5,958,693 |
| 2022-05-16 | Lilly Endowment Inc (10% Owner) | Sale | 80,761 | 302.75 | 24,450,311 |
| 2022-04-08 | Lilly Endowment Inc (10% Owner) | Sale | 139,045 | 310.88 | 43,226,726 |
| 2022-04-07 | Lilly Endowment Inc (10% Owner) | Sale | 70,955 | 310.32 | 22,018,755 |
| 2022-04-06 | Lilly Endowment Inc (10% Owner) | Sale | 51,851 | 301.11 | 15,612,699 |
| 2022-04-05 | Lilly Endowment Inc (10% Owner) | Sale | 113,756 | 294.40 | 33,489,993 |
| 2022-04-04 | Lilly Endowment Inc (10% Owner) | Sale | 39,393 | 293.15 | 11,548,136 |
| 2022-04-01 | Lilly Endowment Inc (10% Owner) | Sale | 165,376 | 292.70 | 48,405,224 |
| 2022-03-30 | Lilly Endowment Inc (10% Owner) | Sale | 2,500 | 292.03 | 730,074 |
| 2022-03-29 | Lilly Endowment Inc (10% Owner) | Sale | 4,341 | 292.69 | 1,270,554 |
| 2022-03-28 | Lilly Endowment Inc (10% Owner) | Sale | 7,538 | 292.15 | 2,202,264 |
| 2022-03-21 | Lilly Endowment Inc (10% Owner) | Sale | 35,245 | 292.74 | 10,317,621 |
| 2022-03-18 | Lilly Endowment Inc (10% Owner) | Sale | 210,000 | 288.40 | 60,563,580 |
| 2022-03-17 | Jonsson Patrik (SVP&Pres, LLY Imm, LLY USA&CCO) | Sale | 673 | 277.20 | 186,555 |
| 2022-03-17 | Lilly Endowment Inc (10% Owner) | Sale | 220,000 | 283.95 | 62,468,780 |
| 2022-03-15 | Lilly Endowment Inc (10% Owner) | Sale | 220,075 | 273.77 | 60,249,492 |
| 2022-03-14 | Lilly Endowment Inc (10% Owner) | Sale | 173,085 | 269.73 | 46,686,390 |
| 2022-03-11 | Lilly Endowment Inc (10% Owner) | Sale | 21,840 | 269.05 | 5,875,986 |
| 2022-03-10 | Lilly Endowment Inc (10% Owner) | Sale | 184,982 | 266.80 | 49,352,642 |
| 2022-03-09 | Lilly Endowment Inc (10% Owner) | Sale | 20,018 | 266.94 | 5,343,544 |
| 2022-03-04 | Lilly Endowment Inc (10% Owner) | Sale | 210,000 | 262.14 | 55,049,190 |
| 2022-03-01 | Jonsson Patrik (SVP&Pres, LLY Imm, LLY USA&CCO) | Sale | 675 | 247.56 | 167,103 |
| 2022-03-01 | Hakim Anat (SVP, GC & Secretary) | Option Ex | 7,929 | .00 | 0 |
| 2022-03-01 | Runge Marschall S | Buy | 202 | 246.78 | 49,849 |
| 2022-02-25 | Zakrowski Donald A (Chief Accounting Officer) | Sale | 1,660 | 243.84 | 404,774 |
| 2022-02-16 | Yuffa Ilya (SVP & President, LLY Int'l) | Sale | 1,000 | 242.58 | 242,580 |
| 2022-02-16 | Van Naarden Jacob (SVP, CEO LoxoONC, Pres LlyONC) | Option Ex | 5,461 | .00 | 0 |
| 2022-02-15 | Yuffa Ilya (SVP & President, LLY Int'l) | Sale | 1,000 | 237.45 | 237,450 |
| 2022-02-01 | White Anne E. (SVP & Pres-Lilly Neuroscience) | Option Ex | 9,368 | .00 | 0 |
| 2022-02-01 | Skovronsky Daniel (SVP, CS&MO & Pres. LRL) | Option Ex | 18,735 | .00 | 0 |
| 2022-02-01 | Pusey Leigh Ann (SVP, Corp. Affairs & Comm.) | Option Ex | 4,416 | .00 | 0 |
| 2022-02-01 | Norton Johna (Senior VP, Global Quality) | Option Ex | 2,676 | .00 | 0 |
| 2022-02-01 | Fry Stephen F (SVP, HR & Diversity) | Option Ex | 10,170 | .00 | 0 |
| 2021-12-30 | Lilly Endowment Inc (10% Owner) | Sale | 3,614 | 279.55 | 1,010,275 |
| 2021-12-27 | Lilly Endowment Inc (10% Owner) | Sale | 3,570 | 279.53 | 997,925 |
| 2021-12-16 | Lilly Endowment Inc (10% Owner) | Sale | 177,616 | 281.39 | 49,979,188 |
| 2021-12-15 | Lilly Endowment Inc (10% Owner) | Sale | 205,000 | 271.49 | 55,654,835 |
| 2021-11-04 | Lilly Endowment Inc (10% Owner) | Sale | 195,000 | 268.86 | 52,426,920 |
| 2021-10-28 | Lilly Endowment Inc (10% Owner) | Sale | 178,631 | 254.46 | 45,454,801 |
| 2021-10-27 | Lilly Endowment Inc (10% Owner) | Sale | 21,369 | 252.33 | 5,391,997 |
| 2021-08-18 | Lilly Endowment Inc (10% Owner) | Sale | 15,430 | 274.31 | 4,232,603 |
| 2021-08-17 | Lilly Endowment Inc (10% Owner) | Sale | 3,060 | 274.08 | 838,697 |
| 2021-08-09 | Lilly Endowment Inc (10% Owner) | Sale | 104,711 | 268.61 | 28,126,002 |
| 2021-08-06 | Lilly Endowment Inc (10% Owner) | Sale | 7,597 | 264.05 | 2,005,965 |
| 2021-08-05 | Lilly Endowment Inc (10% Owner) | Sale | 132,692 | 264.73 | 35,127,022 |
| 2021-08-04 | Lilly Endowment Inc (10% Owner) | Sale | 13,458 | 265.09 | 3,567,608 |
| 2021-08-03 | Lilly Endowment Inc (10% Owner) | Sale | 236,542 | 257.26 | 60,851,848 |
| 2021-07-21 | Lilly Endowment Inc (10% Owner) | Sale | 86,111 | 237.00 | 20,408,307 |
| 2021-07-20 | Lilly Endowment Inc (10% Owner) | Sale | 15,610 | 237.06 | 3,700,428 |
| 2021-07-14 | Lilly Endowment Inc (10% Owner) | Sale | 10,780 | 237.02 | 2,555,118 |
| 2021-07-12 | Lilly Endowment Inc (10% Owner) | Sale | 3,238 | 237.09 | 767,694 |
| 2021-07-09 | Lilly Endowment Inc (10% Owner) | Sale | 109,261 | 237.69 | 25,969,810 |
| 2021-07-06 | Lilly Endowment Inc (10% Owner) | Sale | 210,000 | 235.09 | 49,369,110 |
| 2021-07-02 | Lilly Endowment Inc (10% Owner) | Sale | 202,102 | 233.46 | 47,183,541 |
| 2021-06-24 | Lilly Endowment Inc (10% Owner) | Sale | 12,898 | 237.79 | 3,067,002 |
| 2021-06-09 | Lilly Endowment Inc (10% Owner) | Sale | 220,000 | 225.21 | 49,545,760 |
| 2021-06-07 | Lilly Endowment Inc (10% Owner) | Sale | 230,000 | 226.25 | 52,037,730 |
| 2021-05-24 | Lilly Endowment Inc (10% Owner) | Sale | 7,329 | 202.45 | 1,483,785 |
| 2021-05-21 | Lilly Endowment Inc (10% Owner) | Sale | 92,740 | 200.78 | 18,620,615 |
| 2021-05-20 | Lilly Endowment Inc (10% Owner) | Sale | 99,931 | 200.74 | 20,059,749 |
| 2021-04-30 | Tai Jackson P | Buy | 1,366 | 182.87 | 249,793 |
| 2021-03-09 | Lilly Endowment Inc (10% Owner) | Sale | 59,959 | 210.61 | 12,627,905 |
| 2021-03-08 | Lilly Endowment Inc (10% Owner) | Sale | 125,284 | 209.70 | 26,272,555 |
| 2021-03-01 | Hakim Anat (SVP, GC & Secretary) | Option Ex | 7,928 | .00 | 0 |
| 2021-02-01 | Shah Aarti S. (SVP & CIDO) | Option Ex | 6,282 | .00 | 0 |
| 2021-02-01 | Smiley Joshua L (SVP and CFO) | Option Ex | 19,266 | .00 | 0 |
| 2021-02-01 | O'neill Myles (SVP & Pres., Mfg. Operations) | Option Ex | 12,146 | .00 | 0 |
| 2021-02-01 | Pusey Leigh Ann (SVP, Corp. Affairs & Comm.) | Option Ex | 6,282 | .00 | 0 |
| 2021-02-01 | Norton Johna (Senior VP, Global Quality) | Option Ex | 3,435 | .00 | 0 |
| 2021-02-01 | Zulueta Alfonso G (SVP & President, Lilly Int'l) | Option Ex | 16,754 | .00 | 0 |
| 2021-02-01 | Barnes Melissa S (Chief Eth/Cmpl Ofcr & SVP, ERM) | Option Ex | 5,445 | .00 | 0 |
| 2021-02-01 | Ricks David A (President & CEO) | Option Ex | 75,387 | .00 | 0 |
| 2021-02-01 | Fry Stephen F (SVP, HR & Diversity) | Option Ex | 15,078 | .00 | 0 |
| 2021-01-15 | Lilly Endowment Inc (10% Owner) | Sale | 215,000 | 190.31 | 40,916,865 |
| 2021-01-13 | Lilly Endowment Inc (10% Owner) | Sale | 210,000 | 186.33 | 39,129,510 |
| 2021-01-11 | Lilly Endowment Inc (10% Owner) | Sale | 220,000 | 186.24 | 40,972,140 |
| 2020-10-01 | Smiley Joshua L (SVP and CFO) | Option Ex | 7,947 | .00 | 0 |
| 2020-09-08 | Barnes Melissa S (Chief Eth/Cmpl Ofcr & SVP, ERM) | Sale | 5,000 | 151.01 | 755,050 |
| 2020-09-01 | Mason Michael B (Sr. VP & Pres., Lilly Diabetes) | Option Ex | 6,244 | .00 | 0 |
| 2020-08-17 | Fry Stephen F (SVP, HR & Diversity) | Sale | 7,204 | 150.64 | 1,085,210 |
| 2020-07-09 | Zulueta Alfonso G (SVP & President, Lilly Int'l) | Sale | 11,000 | 170.00 | 1,870,000 |
| 2020-07-09 | Lilly Endowment Inc (10% Owner) | Sale | 12,961 | 170.00 | 2,203,370 |
| 2020-07-07 | Lilly Endowment Inc (10% Owner) | Sale | 210,000 | 167.49 | 35,172,690 |
| 2020-07-06 | Lilly Endowment Inc (10% Owner) | Sale | 205,000 | 167.41 | 34,318,845 |
| 2020-07-05 | Pusey Leigh Ann (SVP, Corp. Affairs & Comm.) | Option Ex | 2,468 | .00 | 0 |
| 2020-06-30 | Lilly Endowment Inc (10% Owner) | Sale | 166,832 | 163.61 | 27,295,383 |
| 2020-06-29 | Lilly Endowment Inc (10% Owner) | Sale | 11,431 | 163.70 | 1,871,243 |
| 2020-06-26 | Lilly Endowment Inc (10% Owner) | Sale | 63,474 | 163.01 | 10,346,832 |
| 2020-06-18 | Lilly Endowment Inc (10% Owner) | Sale | 53,770 | 161.88 | 8,704,072 |
| 2020-06-17 | Lilly Endowment Inc (10% Owner) | Sale | 161,230 | 162.07 | 26,130,062 |
| 2020-06-16 | Zulueta Alfonso G (SVP & President, Lilly Int'l) | Sale | 17,000 | 162.50 | 2,762,500 |
| 2020-06-16 | Lilly Endowment Inc (10% Owner) | Sale | 212,337 | 162.97 | 34,605,410 |
| 2020-06-05 | Zulueta Alfonso G (SVP & President, Lilly Int'l) | Sale | 10,000 | 150.00 | 1,500,000 |
| 2020-04-27 | Lilly Endowment Inc (10% Owner) | Sale | 12,663 | 163.60 | 2,071,717 |
| 2020-04-24 | Lilly Endowment Inc (10% Owner) | Sale | 220,000 | 162.61 | 35,774,200 |
| 2020-04-23 | Lilly Endowment Inc (10% Owner) | Sale | 230,000 | 160.60 | 36,937,080 |
| 2020-04-14 | Shah Aarti S. (SVP & CIO) | Sale | 2,000 | 150.00 | 300,000 |
| 2020-04-09 | Lilly Endowment Inc (10% Owner) | Sale | 230,000 | 145.49 | 33,463,390 |
| 2020-04-07 | Lilly Endowment Inc (10% Owner) | Sale | 172,315 | 143.76 | 24,772,865 |
| 2020-04-06 | Lilly Endowment Inc (10% Owner) | Sale | 15,962 | 142.73 | 2,278,320 |
| 2020-04-03 | Lilly Endowment Inc (10% Owner) | Sale | 26,723 | 143.36 | 3,831,036 |
| 2020-04-02 | Lilly Endowment Inc (10% Owner) | Sale | 166,038 | 141.38 | 23,474,452 |
| 2020-03-31 | Lilly Endowment Inc (10% Owner) | Sale | 38,962 | 140.07 | 5,457,485 |
| 2020-03-30 | Fry Stephen F (SVP, HR & Diversity) | Sale | 14,657 | 135.68 | 1,988,588 |
| 2020-03-30 | Lilly Endowment Inc (10% Owner) | Sale | 210,000 | 139.94 | 29,387,820 |
| 2020-03-16 | Norton Johna (Senior VP, Global Quality) | Sale | 4,727 | 131.00 | 619,237 |
| 2020-03-04 | O'neill Myles (SVP & Pres., Mfg. Operations) | Sale | 25,000 | 140.15 | 3,503,750 |
| 2020-03-02 | Zakrowski Donald A (Chief Accounting Officer) | Sale | 3,700 | 128.00 | 473,600 |
| 2020-02-16 | Norton Johna (Senior VP, Global Quality) | Option Ex | 97 | .00 | 0 |
| 2020-02-05 | Lilly Endowment Inc (10% Owner) | Sale | 200,000 | 146.72 | 29,345,000 |
| 2020-02-01 | Zulueta Alfonso G (SVP & President, Lilly Int'l) | Option Ex | 16,317 | .00 | 0 |
| 2020-02-01 | Barnes Melissa S (Chief Eth/Cmpl Ofcr & SVP, ERM) | Option Ex | 4,896 | .00 | 0 |
| 2020-02-01 | Ricks David A (President & CEO) | Option Ex | 69,350 | .00 | 0 |
| 2020-02-01 | Fry Stephen F (SVP, HR & Diversity) | Option Ex | 13,055 | .00 | 0 |
| 2020-01-13 | Lilly Endowment Inc (10% Owner) | Sale | 205,000 | 139.23 | 28,541,945 |
| 2020-01-10 | Lilly Endowment Inc (10% Owner) | Sale | 210,000 | 138.00 | 28,978,950 |
| 2020-01-09 | Lilly Endowment Inc (10% Owner) | Sale | 220,000 | 136.06 | 29,932,760 |
| 2020-01-08 | Lilly Endowment Inc (10% Owner) | Sale | 172,650 | 133.60 | 23,066,730 |
| 2020-01-07 | Lilly Endowment Inc (10% Owner) | Sale | 32,645 | 132.90 | 4,338,585 |
| 2019-12-20 | Lilly Endowment Inc (10% Owner) | Sale | 19,705 | 132.90 | 2,618,814 |
| 2019-12-18 | Lilly Endowment Inc (10% Owner) | Sale | 220,000 | 129.14 | 28,411,460 |
| 2019-12-17 | Lilly Endowment Inc (10% Owner) | Sale | 215,000 | 125.82 | 27,052,160 |
| 2019-12-09 | Lilly Endowment Inc (10% Owner) | Sale | 10,962 | 119.70 | 1,312,151 |
| 2019-12-06 | O'neill Myles (SVP & Pres., Mfg. Operations) | Sale | 25,000 | 120.00 | 3,000,000 |
| 2019-12-06 | Zulueta Alfonso G (SVP & President, Lilly Int'l) | Sale | 4,500 | 120.00 | 540,000 |
| 2019-12-06 | Lilly Endowment Inc (10% Owner) | Sale | 194,038 | 120.42 | 23,366,832 |
| 2019-12-04 | Lilly Endowment Inc (10% Owner) | Sale | 210,000 | 118.52 | 24,890,040 |
| 2019-11-27 | Lilly Endowment Inc (10% Owner) | Sale | 48,953 | 117.51 | 5,752,271 |
| 2019-11-26 | Lilly Endowment Inc (10% Owner) | Sale | 56,729 | 117.81 | 6,683,470 |
| 2019-11-25 | Lilly Endowment Inc (10% Owner) | Sale | 109,318 | 117.60 | 12,855,796 |
| 2019-11-22 | Lilly Endowment Inc (10% Owner) | Sale | 251,736 | 116.03 | 29,207,921 |
| 2019-11-21 | Lilly Endowment Inc (10% Owner) | Sale | 108,264 | 115.14 | 12,465,516 |
| 2019-11-19 | Lilly Endowment Inc (10% Owner) | Sale | 205,000 | 115.36 | 23,649,415 |
| 2019-11-18 | Lilly Endowment Inc (10% Owner) | Sale | 10,598 | 114.00 | 1,208,172 |
Insider trading activities including stock purchases, stock sales, and option exercises of LLY listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Eli Lilly & Co (symbol LLY, CIK number 59478) see the Securities and Exchange Commission (SEC) website.